RESEARCH TRIANGLE PARK – CNBC’s MadMoney defends IBM stock against a downgrade, Cree is adding jobs, GSK expects a big year for drug approvals, plus news from LabCorp, Charlotte’s Capitala, Marken, Clarkston Consulting and Lumagenics.
Checou out these links:
- CNBC MadMoney questions IBM downgrade
- Cree adding workers in Wisconsin
- IBM joins Red Hat-launched patent group
- GSK CEO aims for six drug approvals in 2020
- Charlotte-based Capitala invests in wireless infrastructure firm
- LabCorp adds genetic tech from Thermo Fisher
- Cary-based Lumagenics names chief operating officer
- Clarkston Consulting promotes four executives
- Triangle-based Marken opens new center in Europe
